PDB52 TYPE-2 DIABETES MODELS THAT DO NOT ACCOUNT FOR MICROVASCULAR DISEASE SCREENING RATESAND IMPORTANT CONCOMITANT MEDICATION USE MAY LEAD TO SUBSTANTIAL MISREPRESENTATION OF THE COST-EFFECTIVENESS OF NEW MEDICATIONS
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67670-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)67670-X/fulltext
Title :
PDB52 TYPE-2 DIABETES MODELS THAT DO NOT ACCOUNT FOR MICROVASCULAR DISEASE SCREENING RATESAND IMPORTANT CONCOMITANT MEDICATION USE MAY LEAD TO SUBSTANTIAL MISREPRESENTATION OF THE COST-EFFECTIVENESS OF NEW MEDICATIONS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67670-X&doi=10.1016/S1098-3015(10)67670-X
First page :
Section Title :
Open access? :
No
Section Order :
256